Related references
Note: Only part of the references are listed.Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Mohammad H. Forouzanfar et al.
LANCET (2011)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Decorin is a novel antagonistic ligand of the Met receptor
Silvia Goldoni et al.
JOURNAL OF CELL BIOLOGY (2009)
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
Judith Hugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Decorin regulates endothelial cell-matrix interactions during angiogenesis
Lorna R. Fiedler et al.
CELL ADHESION & MIGRATION (2009)
Heat Shock Protein 90 Overexpression Independently Predicts Inferior Disease-Free Survival with Differential Expression of the α and β Isoforms in Gastrointestinal Stromal Tumors
Chien-Feng Li et al.
CLINICAL CANCER RESEARCH (2008)
Decorin-mediated effects in cancer cell biology
Alexandros Zafiropoulos et al.
CONNECTIVE TISSUE RESEARCH (2008)
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs
Silvia Goldoni et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of α2β1 integrin activity
Lorna R. Fiedler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
iTRAQ experimental design for plasma biomarker discovery
Xiaomin Song et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells
Alexandros Zafiropoulos et al.
MOLECULAR CANCER RESEARCH (2008)
Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection
G. P. Kuijt et al.
EJSO (2007)
The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra
Ignat V. Shilov et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia
Stephen D. Griffiths et al.
MOLECULAR BIOTECHNOLOGY (2007)
Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling
David Denis Sofeu Feugaing et al.
BIOCHIMIE (2007)
High HSP90 expression is associated with decreased survival in breast cancer
Elah Pick et al.
CANCER RESEARCH (2007)
Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy
C Cox et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
R Bartsch et al.
BMC CANCER (2006)
V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
OM Grbovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin
SD Dias et al.
CANCER RESEARCH (2005)
Decorin, a novel player in the insulin-like growth factor system
E Schönherr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy - A comprehensive review
AS Sreedhar et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA
G Sölétormos et al.
EUROPEAN JOURNAL OF CANCER (2004)
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents
PL Ross et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases
B Becker et al.
EXPERIMENTAL DERMATOLOGY (2004)
Heat-shock proteins as regulators of apoptosis
S Takayama et al.
ONCOGENE (2003)
VEGF165 promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition
S Dias et al.
BLOOD (2002)
Review of sentinel lymph node credentialing: How many cases are enough?
RM Simmons
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2001)
Biological behaviour and clinical implications of micrometastases
MR Kell et al.
BRITISH JOURNAL OF SURGERY (2000)
Modulation of Akt kinase activity by binding to Hsp90
S Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
